Rigel Pharmaceuticals, Inc. (RIGL) Documents: SEC Filings, Investor Presentations & Press Releases

Rigel Pharmaceuticals, Inc. (RIGL) documents, SEC filings and the IR site together: 95 documents, newest first; latest 2026-08-13. Read in-app with summaries. First-party data.

Documents — U.S. SEC EDGAR and the company's IR site
DateTypeDocument
2026-08-13DeckDeck
2026-08-04TranscriptQ2 FY26 earnings call transcript
2026-08-048-KForm 8-K, Item 2.02 results
2026-08-0410-QForm 10-Q for the quarter ended Jun 30
2026-08-04TranscriptQ2 FY26 earnings call transcript
2026-07-018-KForm 8-K, Item 5.02
2026-06-178-KForm 8-K, Item 2.01
2026-05-208-KForm 8-K, Item 5.02
2026-05-12DeckView Presentation
2026-05-128-KForm 8-K, Item 1.01
2026-05-05DeckEarnings Presentation
2026-05-05Press releasePDF
2026-05-058-KForm 8-K, Item 2.02 results
2026-05-0510-QForm 10-Q for the quarter ended Mar 31
2026-04-218-KForm 8-K, Item 1.02
2026-04-03ProxyDefinitive proxy statement
2026-03-04TranscriptQ4 FY25 earnings call transcript
2026-03-038-KForm 8-K, Item 2.02 results
2026-03-0310-KAnnual report on Form 10-K, FY25
2026-02-038-KForm 8-K, Item 5.02
2026-01-128-KForm 8-K, Item 2.02 results
2025-12-108-KForm 8-K, Item 8.01
2025-11-048-KForm 8-K, Item 2.02 results
2025-11-0410-QForm 10-Q for the quarter ended Sep 30
2025-08-058-KForm 8-K, Item 2.02 results
2025-08-0510-QForm 10-Q for the quarter ended Jun 30
2025-05-238-KForm 8-K, Item 5.02
2025-05-068-KForm 8-K, Item 2.02 results
2025-05-0610-QForm 10-Q for the quarter ended Mar 31
2025-04-10ProxyDefinitive proxy statement
2025-03-278-KForm 8-K, Item 8.01
2025-03-108-KForm 8-K, Item 5.02
2025-03-048-KForm 8-K, Item 2.02 results
2025-03-0410-KAnnual report on Form 10-K, FY24
2025-01-138-KForm 8-K, Item 2.02 results
2024-12-098-KForm 8-K, Item 8.01
2024-11-078-KForm 8-K, Item 2.02 results
2024-11-0710-QForm 10-Q for the quarter ended Sep 30
2024-09-198-KForm 8-K, Item 5.02
2024-09-038-KForm 8-K, Item 1.01

RIGL overview · RIGL earnings · RIGL financials · RIGL KPIs · RIGL ownership · RIGL peers

Data sourced from U.S. SEC EDGAR and the company's investor-relations site. Not personalized investment advice.